npr.org
This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
I'm not suggesting any explicit conspiracy here, but I can't help notice a terrifying convergence of incentives. One corporation makes money by selling us cheap, addictive, poisoned food. Another corporation makes money by selling us a partial cure for the poison in our food. The incentives align to never, ever find a better solution to this problem, and to suppress it if it is discovered.
More options
Context Copy link